Bioethics Health Law Policy Human Subjects Research Petrie-Flom Center Population-Level Bioethics Public Health
COVID19
-
-
Adriana Krasniansky Bioethics Digital Health Featured Health Law Policy Insurance Medicare/Medicaid Patient Care Public HealthTelehealth amid COVID-19: What Health Care Providers Should Know
Read more: Telehealth amid COVID-19: What Health Care Providers Should Know -
Old and New Ways of Coping with COVID-19: Ethics Matters (Part II)
Read more: Old and New Ways of Coping with COVID-19: Ethics Matters (Part II) -
What Does It Mean That Oracle is Partnering with the Trump Administration to Study Unproven COVID-19 Drugs?
Read more: What Does It Mean That Oracle is Partnering with the Trump Administration to Study Unproven COVID-19 Drugs? -
Bioethics Health Law Policy History Leslie Francis Philosophy Population-Level Bioethics Public HealthOld and New Ways of Coping with COVID-19: Ethics Matters (Part I)
Read more: Old and New Ways of Coping with COVID-19: Ethics Matters (Part I) -
Pandemic Guidelines, Not Changed Malpractice Rules, Are the Right Response to COVID-19
Read more: Pandemic Guidelines, Not Changed Malpractice Rules, Are the Right Response to COVID-19 -
Anonymity in the Time of a Pandemic: Privacy vs. Transparency
Read more: Anonymity in the Time of a Pandemic: Privacy vs. Transparency -
Bioethics Featured Health Law Policy Patient Care Population-Level Bioethics Public Health Resource Allocation3 Human Rights Imperatives for Rationing Care in the Time of Coronavirus
Read more: 3 Human Rights Imperatives for Rationing Care in the Time of Coronavirus -
Call for Submissions: Journal of Law and Biosciences, “Law and Ethics in the Time of a Global Pandemic”
Read more: Call for Submissions: Journal of Law and Biosciences, “Law and Ethics in the Time of a Global Pandemic” -
Contributors Doctor-Patient Relationship Featured Health Law Policy Nicolas Terry Opioid Crisis Patient Care Public HealthProtecting the Vulnerable Substance Use Disorder Population During COVID-19
Read more: Protecting the Vulnerable Substance Use Disorder Population During COVID-19